Consainsights logo
Reports / Infantile Spasms Therapeutics Market

Infantile Spasms Therapeutics Market

Infantile Spasms Therapeutics Market Research Report – Segmented By Formulation Type (LIQUID, SOLID), Route Of Administration (ORAL, PARENTERAL) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Infantile Spasms Therapeutics Market was valued at US $147.42 million in 2021 and is projected to grow at 3.70% CAGR over the forecast period to reach US $183.33 million by 2027. Infantile Spasms Therapeutics Market represented US $10.33 million opportunity over 2019-2021 and estimated to create US $35.91 million opportunity in 2027 over 2021.

Infantile Spasms Therapeutics from Consainsights analyses the Infantile Spasms Therapeutics Market in the Life Sciences industry over the forecast period to 2027.

Infantile Spasms Therapeutics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Infantile Spasms Therapeutics segmentation includes Formulation Type, Route Of Administration and Geography.

Based on the Formulation Type, the Infantile Spasms Therapeutics analysis covers SOLID, LIQUID.

In Formulation Type segment, SOLID segment has highest cagr growth of 3.28%.

Based on the Route Of Administration, the Infantile Spasms Therapeutics analysis covers ORAL, PARENTERAL.

In Route Of Administration segment, ORAL segment has highest cagr growth of 3.28%.

Based on the region, the Infantile Spasms Therapeutics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include VALERION THERAPEUTICS, ANAVEX LIFE SCIENCES CORP., GW PHARMACEUTICALS, PLC., MALLINCKRODT, H. LUNDBECK A/S, ORPHELIA PHARMA SA, INSYS THERAPEUTICS, INC., ETROPHIN, INC., CATALYSTPHARMA and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Formulation Type (2021)
    Revenue Share (%), By Formulation Type (2021)
  • Revenue Share (%), By Route Of Administration (2021)
    Revenue Share (%), By Route Of Administration (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Formulation Type

  • SOLID accounted for US$93.72 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • LIQUID accounted for US$53.70 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Infantile Spasms Therapeutics Market Y-o-Y Growth (USD million), By Formulation Type 2019 - 2027
Infantile Spasms Therapeutics Market Y-o-Y Growth (USD million), By Formulation Type 2019 - 2027
Infantile Spasms Therapeutics Market Size, By Formulation Type, 2019-2027 (USD million)
Infantile Spasms Therapeutics Market Size, By Formulation Type, 2019-2027 (USD million)

The LIQUID segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

LIQUID: global Infantile Spasms Therapeutics Market Revenue Opportunity (Us$ Mn)
LIQUID: global Infantile Spasms Therapeutics Market Revenue Opportunity (Us$ Mn)

The SOLID segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

SOLID: global Infantile Spasms Therapeutics Market Revenue Opportunity (Us$ Mn)
SOLID: global Infantile Spasms Therapeutics Market Revenue Opportunity (Us$ Mn)
04

By Route Of Administration

  • ORAL accounted for US$99.82 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • PARENTERAL accounted for US$47.60 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Infantile Spasms Therapeutics Market Y-o-Y Growth (USD million), By Route Of Administration 2019 - 2027
Infantile Spasms Therapeutics Market Y-o-Y Growth (USD million), By Route Of Administration 2019 - 2027
Infantile Spasms Therapeutics Market Size, By Route Of Administration, 2019-2027 (USD million)
Infantile Spasms Therapeutics Market Size, By Route Of Administration, 2019-2027 (USD million)

The ORAL segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ORAL: global Infantile Spasms Therapeutics Market Revenue Opportunity (Us$ Mn)
ORAL: global Infantile Spasms Therapeutics Market Revenue Opportunity (Us$ Mn)

The PARENTERAL segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

PARENTERAL: global Infantile Spasms Therapeutics Market Revenue Opportunity (Us$ Mn)
PARENTERAL: global Infantile Spasms Therapeutics Market Revenue Opportunity (Us$ Mn)
05

North America

  • In 2021, North America segment accounted for US$147.42 Bn and is expected grow with a CAGR of 3.70% over the forecast years.
  • In North America, United States accounted for US$109.97 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$37.45 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
North America Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
North America Infantile Spasms Therapeutics Market - Market Opportunity (USD million), 2019, 2021 & 2027
North America Infantile Spasms Therapeutics Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Formulation Type - North America (2021)
Revenue Share (%), By Formulation Type - North America (2021)
Revenue Share (%), By Route Of Administration - North America (2021)
Revenue Share (%), By Route Of Administration - North America (2021)
North America Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
North America Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
United States Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
United States Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
United States Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
United States Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Canada Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Canada Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Canada Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Canada Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
06

Europe

  • In 2021, Europe segment accounted for US$147.42 Bn and is expected grow with a CAGR of 3.70% over the forecast years.
  • In Europe, Germany accounted for US$59.61 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$35.59 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$20.13 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$11.88 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$8.78 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$6.50 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$4.93 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Europe Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Europe Infantile Spasms Therapeutics Market - Market Opportunity (USD million), 2019, 2021 & 2027
Europe Infantile Spasms Therapeutics Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Formulation Type - Europe (2021)
Revenue Share (%), By Formulation Type - Europe (2021)
Revenue Share (%), By Route Of Administration - Europe (2021)
Revenue Share (%), By Route Of Administration - Europe (2021)
Europe Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Europe Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Germany Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Germany Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Germany Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Germany Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
United Kingdom Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
United Kingdom Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
United Kingdom Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
United Kingdom Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
France Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
France Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
France Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
France Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Spain Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Spain Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Spain Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Spain Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Russia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Russia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Russia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Russia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Italy Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Italy Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Italy Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Italy Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Rest of Europe Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Europe Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Europe Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Rest of Europe Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
07

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$147.42 Bn and is expected grow with a CAGR of 3.70% over the forecast years.
  • In Asia-Pacific, China accounted for US$60.87 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$33.14 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$23.95 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$10.80 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$13.37 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$5.29 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Asia-Pacific Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Asia-Pacific Infantile Spasms Therapeutics Market - Market Opportunity (USD million), 2019, 2021 & 2027
Asia-Pacific Infantile Spasms Therapeutics Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Formulation Type - Asia-Pacific (2021)
Revenue Share (%), By Formulation Type - Asia-Pacific (2021)
Revenue Share (%), By Route Of Administration - Asia-Pacific (2021)
Revenue Share (%), By Route Of Administration - Asia-Pacific (2021)
Asia-Pacific Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Asia-Pacific Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
China Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
China Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
China Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
China Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Japan Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Japan Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Japan Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Japan Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
India Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
India Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
India Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
India Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Southeast Asia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Southeast Asia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Southeast Asia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Southeast Asia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Australia & New Zealand Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Australia & New Zealand Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Australia & New Zealand Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Australia & New Zealand Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Rest of Asia-Pacific Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Asia-Pacific Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Asia-Pacific Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Rest of Asia-Pacific Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Infantile Spasms Therapeutics Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Infantile Spasms Therapeutics Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Infantile Spasms Therapeutics Size, 2019-2027 (Us$ Mn)
Middle East & Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Middle East & Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Middle East & Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Middle East & Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Middle East Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Middle East Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Middle East Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Middle East Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Rest of Middle East & Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Middle East & Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Middle East & Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Rest of Middle East & Africa Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
09

Latin America

  • In 2021, Latin America segment accounted for US$147.42 Bn and is expected grow with a CAGR of 3.70% over the forecast years.
  • In Latin America, Brazil accounted for US$51.15 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$40.14 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$28.16 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$20.08 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$7.89 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Latin America Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Latin America Infantile Spasms Therapeutics Market - Market Opportunity (USD million), 2019, 2021 & 2027
Latin America Infantile Spasms Therapeutics Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Formulation Type - Latin America (2021)
Revenue Share (%), By Formulation Type - Latin America (2021)
Revenue Share (%), By Route Of Administration - Latin America (2021)
Revenue Share (%), By Route Of Administration - Latin America (2021)
Latin America Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Latin America Infantile Spasms Therapeutics Market, By Country, 2019-2027 (USD million)
Brazil Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Brazil Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Brazil Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Brazil Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Argentina Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Argentina Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Argentina Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Argentina Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Mexico Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Mexico Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Mexico Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Mexico Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Colombia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Colombia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Colombia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Colombia Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Rest of Latin America Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Latin America Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Latin America Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
Rest of Latin America Infantile Spasms Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route Of Administration, 2019-2027
10

Company Analysis

  • VALERION THERAPEUTICS
  • ANAVEX LIFE SCIENCES CORP.
  • GW PHARMACEUTICALS, PLC.
  • MALLINCKRODT
  • H. LUNDBECK A/S
  • ORPHELIA PHARMA SA
  • INSYS THERAPEUTICS, INC.
  • ETROPHIN, INC.
  • CATALYSTPHARMA